Document is current
Any future updates will be listed below
-
Authors
Gao, Leili
Lee, Byung Wan
Chawla, Manoj
Kim, Joshua
Huo, Li
Du, Liying
Huang, Yan
Ji, Linong https://orcid.org/0000-0002-3262-2168
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (NA, NA)
- License Information
-
More Information
Article History
Received: 10 November 2022
Accepted: 7 April 2023
First Online: 25 May 2023
Competing interests
: L.H., L.D. and Y.H. are employees of Eli Lilly and Company. L.J. reports receiving consulting and lecture fees from Eli Lilly and Company, Novo Nordisk, Merck, Bayer, Sanofi-Aventis, Roche, Merck Sharp & Dohme, Metronics, AstraZeneca, Boehinger Ingelheim and Abbott. L.J. and L.G. received a research grant for this study from Eli Lilly and Company. M.C. reports having speaker contracts with Novo Nordisk, Sanofi, Biocon, Cipla, USV Ltd. and Abbott. The other authors declare no competing interests.
